Deficits of [3H]D-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia.
The hypothesis involving glutamate in the neuropathology of schizophrenia has attracted great interest. Several studies report dysfunctions in glutamatergic systems, including alterations in kainate and N-methyl-D-aspartate (NMDA) receptors in various areas, as well as changes in the number of glutamate uptake sites. We have studied this further using [3H]D-aspartate binding to glutamate uptake sites as a measure of the integrity of presynaptic glutamate systems in several areas (caudate nucleus, putamen, nucleus accumbens, frontal cortex and temporal cortex) of brain tissue taken at autopsy from schizophrenic patients and controls. A significant decrease in the number of glutamate uptake sites was apparent in caudate nucleus, putamen and nucleus accumbens in the schizophrenia group, indicating an impaired glutamatergic innervation of these subcortical regions. However, no significant changes were found in the two cortical regions studied.
Aparicio-Legarza
M I
MI
Department of Biomedical Science, University of Sheffield, UK.
Cutts
A J
AJ
Davis
B
B
Reynolds
G P
GP
D000368:Aged; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism / Q000494:pharmacology*; D003342:Corpus Striatum / Q000737:chemistry* / Q000378:metabolism; D005260:Female; D005625:Frontal Lobe / Q000737:chemistry / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009714:Nucleus Accumbens / Q000737:chemistry* / Q000378:metabolism; D011869:Radioligand Assay; D051381:Rats; D017208:Rats, Wistar; D017470:Receptors, Glutamate / Q000032:analysis / Q000378:metabolism; D012559:Schizophrenia / Q000378:metabolism*; D013570:Synaptic Membranes / Q000737:chemistry / Q000378:metabolism; D014316:Tritium
D017470:Receptors, Glutamate; D014316:Tritium; D001224:Aspartic Acid; D018698:Glutamic Acid